ROLE: ART DIRECTION & DESIGN
Light Your Own Way With JEMPERLI
1 in 4 endometrial cancer patients face recurrence or metastasis. Doctors struggle with limited treatment options, leaving patients feeling overwhelmed. JEMPERLI offers the first-approved 1L A/R immunotherapy, allowing patients to live life on their terms. The Patient Light campaign honors the strength and resilience of endometrial cancer patients, empowering them to embrace their treatment journey with hope.
JEMPERLI will provide a “welcome kit” to every patient who starts the treatment. The welcome kit houses informational brochures and other supportive materials. Between these, patients can find a welcome letter, a patient brochure, a care partner guide for their loved ones, a wellness guide with lifestyle tips, a discussion guide to be prepared for their doctor’s appointments, and a side effects management guide.
National Sales Meeting: Day One of the 2023 National Sales Meeting will be utilized as a forum to mark the launch of Ruby 1L for JEMPERLI. The objective of this work is to provide emotive engagement that will rally the sales force and create a deeper connection to the patient panel.
“Find me in Endometrial Cancer”: We wanted to build excitement and a sense of connection to our patient panelists. Having attendees reveal who the panelists are by using empowering words helps build that connection, humanize people with EC, and bring attendees together engaged towards a common goal.
Pre-NSM: On the days preceding the event, sales representatives received quotes from one of our panelists (through the SpotMe app) and were asked to select a single word that best describes the person behind the quote.
During NSM: On entry into the patient panel, the two screens played an animation using the word options from the poll — an illustration of the three patient panelists was revealed alongside a powerful statement.
Post NSM: Video snippets with highlights from the panel will be sent to the reps via email as a reminder of why we do what we do
